학술논문
Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease.
Document Type
Article
Author
Source
Subject
*MUSCULOSKELETAL system diseases
*STATISTICS
*IMMUNIZATION
*CONFIDENCE intervals
*COVID-19 vaccines
*MULTIVARIATE analysis
*QUESTIONNAIRES
*DESCRIPTIVE statistics
*RHEUMATISM
*LOGISTIC regression analysis
*ODDS ratio
*PATIENT safety
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1462-0324
Abstract
The article discusses a study on the safety of third-dose (D3) SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease (RMD). Topics include the most common local and systemic reactions, limitations of the study, and characteristics of RMD patients, stratified by presence/absence of disease flare requiring treatment and multivariable analysis of factors associated with post-D3 flare.